10 September 2018
A new report by visiongain predicts that the Pre-Filled Syringes market will reach $6,940m in 2020. This forecast and others appear in Pre-Filled Syringes Market Forecast 2016-2026: Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes published in April 2016. Visiongain is a business information provider based in London, UK.
The Pre-Filled Syringes Market Forecast 2016-2026 report examines the current and future trends in the growing pre-filled syringes market. Glass syringes have long dominated the market, however the improved characteristics of plastic syringes, an increasing adoption of autoinjectors and pen injectors, as well as the advent of needle-free delivery systems are posing a threat to the continued dominance of glass syringes. The large number of injectable drugs in the pipeline and increasing number of approved biosimilars is helping to spur demand for pre-filled syringes, despite newer oral therapies being much preferred by patients.
In this report, we examine in detail some of the main national markets in the market, analyse and forecast the major treatment areas that use pre-filled syringes, as well as forecast specific products that are delivered in pre-filled syringes. In addition, the report includes an in-depth discussion of the main companies in the market, including historical revenues and product details when available. Qualitative analysis of the market is given, taking into account governmental policy and regulation, safety, features and more.
Visiongain’s report provides revenue forecasts to 2026 for the Pre-Filled Syringes market, its leading national markets, therapeutics areas and products. The report discusses selected leading companies in the market. These companies include Becton, Dickinson and Company, Gerresheimer, Schott, Baxter, Nipro, Weigao, Unilife, Roselabs, SHL Group, Ypsomed, Haselmeier, Owen Mumford, Bespak and Datwyler.
Pre-Filled Syringes Market Forecast 2016-2026: Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For an executive summary please contact:
Email: Sara Peerun on firstname.lastname@example.org
Tel: +44 (0) 20 7336 6100
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.
Maintaining the quality and safety of the product in the supply chain has always been a high priority for pharmaceutical companies. New market dynamics including an evolving product line, more stringent regulations, geographically connected supply chains, rising risk, and extreme cost pressure have raised stakes significantly.
28 September 2020
The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.
23 September 2020
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.